Drug profile · INN
chlorpheniramine maleate
CHLORPHENIRAMINE MALEATE
chlorpheniramine maleate (CHLORPHENIRAMINE MALEATE) is a histamine h1 receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Drug details — chlorpheniramine maleate
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 3
- Data quality
- 0.89
Quick answer
chlorpheniramine maleate (CHLORPHENIRAMINE MALEATE) is a histamine h1 receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Histamine H1 receptor antagonist
Primary target: Histamine H1 receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is chlorpheniramine maleate?
chlorpheniramine maleate (CHLORPHENIRAMINE MALEATE) is a histamine h1 receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for chlorpheniramine maleate?
CHLORPHENIRAMINE MALEATE is a marketed brand name for chlorpheniramine maleate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of chlorpheniramine maleate?
chlorpheniramine maleate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.